As Wolverine World Wide (WWW) Share Value Rose, Parametric Portfolio Associates Has Decreased Its Holding by $1.29 Million; As Alexion Pharmaceuticals (ALXN) Stock Price Declined, Webster Bank Lowered Its Stake

Wolverine World Wide, Inc. (NYSE:WWW) Logo

Webster Bank decreased its stake in Alexion Pharmaceuticals Inc (ALXN) by 30% based on its latest 2018Q1 regulatory filing with the SEC. Webster Bank sold 3,000 shares as the company’s stock declined 2.96% with the market. The institutional investor held 7,000 shares of the health care company at the end of 2018Q1, valued at $780,000, down from 10,000 at the end of the previous reported quarter. Webster Bank who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be less bullish one the $27.07 billion market cap company. The stock decreased 0.15% or $0.18 during the last trading session, reaching $121.66. About 1.24 million shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has risen 19.53% since June 29, 2017 and is uptrending. It has outperformed by 6.96% the S&P500. Some Historical ALXN News: 15/03/2018 – Alexion Pharmaceuticals: Safety Profile of ALXN1210 Consistent With That Seen for Soliris; 11/04/2018 – Alexion To Acquire Wilson Therapeutics; 26/04/2018 – ALEXION PHARMACEUTICALS INC SEES 2018 SOLIRIS REVENUES OF $3,380 MLN TO $3,420 MLN; 26/04/2018 – Alexion Pharmaceuticals 1Q Adj EPS $1.68; 21/04/2018 – DJ Alexion Pharmaceuticals Inc, Inst Holders, 1Q 2018 (ALXN); 11/04/2018 – ALEXION PHARMACEUTICALS INC ALXN.O SAYS TOTAL EQUITY VALUE OF TRANSACTION AMOUNTS TO SEK 7,100 MLN, OR APPROXIMATELY $855 MLN; 11/04/2018 – Alexion to Buy Wilson for $790 Million for Rare Drug (Correct); 11/04/2018 – Alexion Will Acquire Wilson Through a Tender OfferWhereby Alexion, Through Subsidiary, Has Offered SEK232 in Cash for Each Outstanding Share of Wilson; 26/04/2018 – Alexion Pharmaceuticals Sees FY Adj EPS $6.60-Adj EPS $6.80; 15/03/2018 – Alexion Pharmaceuticals: Regulatory Submissions Planned in the U.S., EU and Japan in the 2H of 2018

Parametric Portfolio Associates Llc decreased its stake in Wolverine World Wide Inc (WWW) by 13% based on its latest 2018Q1 regulatory filing with the SEC. Parametric Portfolio Associates Llc sold 46,189 shares as the company’s stock rose 10.01% while stock markets declined. The institutional investor held 309,151 shares of the consumer non-durables company at the end of 2018Q1, valued at $8.93M, down from 355,340 at the end of the previous reported quarter. Parametric Portfolio Associates Llc who had been investing in Wolverine World Wide Inc for a number of months, seems to be less bullish one the $3.35 billion market cap company. The stock increased 0.51% or $0.18 during the last trading session, reaching $35.37. About 445,242 shares traded. Wolverine World Wide, Inc. (NYSE:WWW) has risen 31.74% since June 29, 2017 and is uptrending. It has outperformed by 19.17% the S&P500. Some Historical WWW News: 07/05/2018 – WOLVERINE WORLD WIDE SAYS SIZE OF BOARD WAS REDUCED FROM ELEVEN TO TEN UPON RETIREMENT OF TIMOTHY O’DONOVAN – SEC FILING; 07/05/2018 – Wolverine World Wide: Size of Board Reduced to 10 Seats From 11; 09/05/2018 – Wolverine World Wide Volume Surges Almost 18 Times Average; 10/05/2018 – OPTIMIZERX HOLDER WOLVERINE URGES COMPANY TO PURSUE SALE; 09/05/2018 – WOLVERINE WORLD WIDE INC WWW.N SEES FY REVENUE $2.24 BLN TO $2.32 BLN; 09/05/2018 – Wolverine World Wide 1Q-End Inventory Down 18.5%; 09/05/2018 – WOLVERINE WORLD WIDE INC WWW.N SEES FY ADJUSTED SHR $2.00 TO $2.10; 09/05/2018 – Wolverine World Wide 1Q Net $46.7M; 19/03/2018 Large retailers urge Trump against China tariffs; 09/05/2018 – Wolverine World Wide Sees 2018 EPS $1.92-EPS $2.02

Analysts await Wolverine World Wide, Inc. (NYSE:WWW) to report earnings on August, 8. They expect $0.45 EPS, up 4.65% or $0.02 from last year’s $0.43 per share. WWW’s profit will be $42.65 million for 19.65 P/E if the $0.45 EPS becomes a reality. After $0.50 actual EPS reported by Wolverine World Wide, Inc. for the previous quarter, Wall Street now forecasts -10.00% negative EPS growth.

Investors sentiment decreased to 1.01 in 2018 Q1. Its down 0.12, from 1.13 in 2017Q4. It dived, as 21 investors sold WWW shares while 88 reduced holdings. 39 funds opened positions while 71 raised stakes. 86.46 million shares or 1.80% less from 88.04 million shares in 2017Q4 were reported. Oppenheimer Asset, New York-based fund reported 44,602 shares. Teacher Retirement Of Texas has invested 0% in Wolverine World Wide, Inc. (NYSE:WWW). Gsa Capital Prns Llp reported 0.04% of its portfolio in Wolverine World Wide, Inc. (NYSE:WWW). The Hong Kong-based Point72 Asia (Hong Kong) has invested 0.08% in Wolverine World Wide, Inc. (NYSE:WWW). Gemmer Asset Mngmt Ltd Limited Liability Company holds 256 shares or 0% of its portfolio. Stifel Corp invested in 0% or 48,378 shares. Arizona State Retirement System has 151,509 shares for 0.04% of their portfolio. Comerica Bancorp has invested 0.02% of its portfolio in Wolverine World Wide, Inc. (NYSE:WWW). Credit Suisse Ag stated it has 0% in Wolverine World Wide, Inc. (NYSE:WWW). Friess Associate Limited Company reported 549,122 shares. Anchor Cap Lc reported 37,370 shares. New York State Common Retirement Fund holds 685,044 shares. Invesco Limited holds 0.02% or 1.41 million shares. 413,334 are held by Heartland Advsr. Panagora Asset owns 8,181 shares.

Parametric Portfolio Associates Llc, which manages about $101.37B US Long portfolio, upped its stake in Target Corp (NYSE:TGT) by 212,856 shares to 2.21M shares, valued at $153.44 million in 2018Q1, according to the filing. It also increased its holding in New Senior Investment Group (NYSE:SNR) by 84,648 shares in the quarter, for a total of 354,995 shares, and has risen its stake in Simmons First National Corp (NASDAQ:SFNC).

Since February 23, 2018, it had 0 insider purchases, and 8 selling transactions for $5.94 million activity. On Friday, February 23 the insider GERBER WILLIAM K sold $174,633. On Friday, February 23 the insider LAUDERBACK BRENDA J sold $187,659. Another trade for 16,180 shares valued at $481,031 was sold by ODONOVAN TIMOTHY J. JEPPESEN MICHAEL sold $551,848 worth of stock. $187,723 worth of Wolverine World Wide, Inc. (NYSE:WWW) was sold by KOLLAT DAVID T. $124,614 worth of Wolverine World Wide, Inc. (NYSE:WWW) was sold by Klimek Amy M..

Among 17 analysts covering Wolverine (NYSE:WWW), 6 have Buy rating, 2 Sell and 9 Hold. Therefore 35% are positive. Wolverine had 54 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was upgraded by DA Davidson to “Buy” on Thursday, February 22. The stock has “Market Perform” rating by Telsey Advisory Group on Wednesday, October 21. Susquehanna initiated the stock with “Negative” rating in Friday, August 12 report. The stock of Wolverine World Wide, Inc. (NYSE:WWW) has “Hold” rating given on Thursday, September 14 by Piper Jaffray. The stock of Wolverine World Wide, Inc. (NYSE:WWW) earned “Hold” rating by Piper Jaffray on Wednesday, August 12. The stock has “Hold” rating by Stifel Nicolaus on Monday, August 10. The stock of Wolverine World Wide, Inc. (NYSE:WWW) earned “Neutral” rating by Buckingham Research on Thursday, November 9. On Friday, October 20 the stock rating was maintained by Robert W. Baird with “Buy”. As per Wednesday, October 21, the company rating was maintained by Citigroup. The stock of Wolverine World Wide, Inc. (NYSE:WWW) has “Neutral” rating given on Wednesday, October 21 by B. Riley & Co.

Since January 2, 2018, it had 1 insider purchase, and 16 selling transactions for $4.25 million activity. 1,645 shares were sold by Goff Brian, worth $194,982 on Friday, June 8. The insider Franchini Indrani Lall sold $169,696. 1,261 shares valued at $147,865 were sold by Moriarty John B on Monday, February 5. $248,474 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares were sold by O’Neill Julie. 655 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares with value of $76,805 were sold by Wagner Heidi L. The insider HANTSON LUDWIG sold $310,521.

Investors sentiment decreased to 1 in 2018 Q1. Its down 0.03, from 1.03 in 2017Q4. It worsened, as 43 investors sold ALXN shares while 184 reduced holdings. 60 funds opened positions while 167 raised stakes. 200.94 million shares or 1.68% less from 204.38 million shares in 2017Q4 were reported. Arizona State Retirement Sys holds 0.06% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 55,004 shares. Baystate Wealth Management Ltd Liability Co invested 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Clearbridge Ltd Liability Corporation owns 847,498 shares or 2.1% of their US portfolio. 82,767 were reported by Oak Ridge Invests Ltd Liability Corp. Liberty Mutual Gp Asset Management has 8,895 shares for 0.03% of their portfolio. Sequent Asset Management Ltd Liability Corporation has invested 0.36% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Columbus Circle accumulated 188,836 shares. Tudor Investment Et Al stated it has 20,202 shares or 0.07% of all its holdings. Pura Vida Invests Ltd Liability Co reported 0% stake. Dupont Capital accumulated 1,973 shares or 0.01% of the stock. Howe And Rusling reported 54 shares or 0% of all its holdings. Nine Masts Capital Limited accumulated 0.43% or 24,977 shares. Sectoral Asset Management owns 96,000 shares. Utah Retirement Systems owns 40,103 shares for 0.1% of their portfolio. Pinebridge LP holds 1,744 shares or 0% of its portfolio.

Webster Bank, which manages about $692.59 million US Long portfolio, upped its stake in Ishares Etfs/Usa (GVI) by 3,667 shares to 23,472 shares, valued at $2.54M in 2018Q1, according to the filing. It also increased its holding in Vanguard (VOO) by 14,172 shares in the quarter, for a total of 173,233 shares, and has risen its stake in Charles Schwab Corp/The (NYSE:SCHW).

Analysts await Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to report earnings on July, 26. They expect $1.47 earnings per share, up 12.21% or $0.16 from last year’s $1.31 per share. ALXN’s profit will be $327.07 million for 20.69 P/E if the $1.47 EPS becomes a reality. After $1.53 actual earnings per share reported by Alexion Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -3.92% negative EPS growth.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart